Loading organizations...
Loading organizations...
Design and develop therapeutic peptides for oncology and immune diseases.
PeptiMimesis has raised $1.3M across 2 funding rounds.
PeptiMimesis has raised $1.3M in total across 2 funding rounds.
PeptiMimesis has raised $1.3M in total across 2 funding rounds.
PeptiMimesis's investors include Capital Grand Est.
PeptiMimesis has raised $1.3M across 2 funding rounds. Most recently, it raised $740K Seed Extension in March 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 15, 2017 | $740K Seed Extension | Capital Grand Est | |
| Apr 20, 2016 | $570K Other Equity | Capital Grand Est |